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A B S T R A C T
Early life stress (ELS) leads to a permanent reprogramming of biochemical stress response cascades that may also
be relevant for the processing of chronic pain states such as neuropathy. Despite clinical evidence, little is known
about ELS-related vulnerability for neuropathic pain and the possibly underlying etiology.
In the framework of experimental studies aimed at investigating the respective relationships we used the
established ELS model of maternal separation (MS). Rat dams and neonates were separated for 3 h/day from
post-natal day 2–12. At adulthood, noxious mechanical and thermal thresholds were assessed before and during
induction of neuropathic pain by chronic constriction injury (CCI). The potential involvement of spinal gluta-
matergic transmission, glial cells, pro-inﬂammatory cytokines and growth factors was studied by using qPCR.
MS per se did not modify pain thresholds. But, when exposed to neuropathic pain, MS rats exhibited a marked
reduction of thermal sensitivity and a delayed development of mechanical allodynia/hyperalgesia when com-
pared to control animals. Also, MS did not alter glucocorticoid receptor mRNA levels, but prevented the CCI-
induced down-regulation of NR1 and NR2 sub-units of the NMDA receptor and of the glutamate transporter
EAAT3 as observed at 21 days post-surgery. Additionally, CCI-provoked up-regulation of glial cell markers was
either prevented (GFAP for astrocytes) or dampened (Iba1 for microglia) by MS. Pro-inﬂammatory cytokine
mRNA expression was either not aﬀected (IL-6) or reduced (IL-1β) by MS shortly after CCI. The growth factors
GDNF and NGF were only slightly downregulated 4 days after CCI in the MS-treated animals. The changes in
glutamatergic signaling, astroglial and cytokine activation as well as neurotrophin expression could, to some
extent, explain these changes in pain behavior. Taken together, the results obtained in the described experi-
mental conditions support the mismatch theory of chronic stress where an early life stress, rather than predis-
posing individuals to certain pathologies, renders them resilient.
1. Introduction
The nervous and the immune system are involved in the stress re-
sponse as well as in the processing of pain (Krishnan and Nestler, 2008;
Schwaller and Fitzgerald, 2014). Stress-related structural or functional
modiﬁcations within these systems are hence likely to impact pain
sensitivity (Sandkühler, 2009). Early life is a critical period for the
normal development of individuals. Preclinical (Schmidt, 2010) and
clinical (Heim et al., 2010) studies have demonstrated that early life
stress can have a major impact on neuronal circuits and immune system
development, possibly leading to enhanced vulnerability to physio- and
psychopathological states at adulthood. A well-established way of
modelling early life stress in rodents is to expose new-born pups to
maternal separation (MS) (Levine, 2001). MS has been shown to induce
abnormal development of immune and nervous systems (Roque et al.,
2015). Among these perturbations is a long term modiﬁcation of the
central neuronal circuitry involved in relaying noxious stimuli and in
controlling pain sensitivity during normal and pathological states
(Chung et al., 2007; Uhelski and Fuchs, 2010; Weaver et al., 2007).
Neuropathic pain is a chronic pain state that generally occurs following
nerve damage. As a consequence, signiﬁcant peripheral and central
remodeling leads to enhanced pain sensitivity (hyperalgesia), induction
of pain by a normally non painful stimulus (allodynia) and to sponta-
neous pain (for review see: von Hehn et al., 2012). Despite signiﬁcant
advances in basic and clinical research, this condition remains diﬃcult
to treat since our understanding of the underlying pathophysiological
mechanisms is still insuﬃcient (von Hehn et al., 2012).
Although spinal synaptic transmission of noxious stimuli constitutes
the ﬁrst relay of this network, it has scarcely been studied in the context
of stress. Among the molecular mediators involved in nociceptive
transmission and in the establishment of neuropathic pain, several key
players such as the glucocorticoid receptor (GR) (Ladd et al., 2004;
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Wang et al., 2005), glutamatergic receptors and transporters (Toya
et al., 2014), cytokines (Alvarez et al., 2013) and neurotrophins (Faure
et al., 2007) are modulated by MS. Thus, it seems plausible that MS
could have an impact on neuropathic pain vulnerability at least in a
subset of individuals. In addition changes of neuro-immune and/or
neuroendocrine systems induced by chronic stress could facilitate or
hamper the development of chronic pain independently of classical
stress processing pathways. To our knowledge, no study has in-
vestigated the eﬀect of MS on pain thresholds and potential spinal
molecular mediators involved in the change of nociceptive transmission
under conditions of neuropathy. In the present work we used beha-
vioral (mechanical and thermal thresholds) and biochemical (mRNA
expression of spinal markers) approaches to assess the impact of MS on
the onset and the maintenance of neuropathic pain. In order to induce
this pain condition, we decided to use the well-established chronic
constriction injury (CCI) model initially described by Bennett and Xie
(1988).
2. Material and methods
2.1. Animals
Female (nulliparous) and male Sprague Dawley rats were purchased
from Harlan Laboratories (Netherland). They were then reared in our
facility to provide the oﬀspring used for the experimental studies. All
animals were housed under standardized conditions: temperature con-
trolled room (21–23 °C), relative humidity 60 ± 10%, 12 h light/dark
cycle, food and water provided ad libitum. Rats were only brieﬂy han-
dled twice per week during the cage changes. Except for the maternal
separation procedure in the respective groups, pups were left un-
disturbed until weaning at post-natal day 21. Experiments started when
the animals reached the age of 8 weeks.
Animals were divided in 4 groups (see Fig. 1) depending on the
stress and pain conditions they were exposed to: controls CON (no MS,
no CCI; n = 10), CON+CCI (no MS but CCI; n = 15), MS (MS but no
CCI; n = 15), and MS+CCI (MS and CCI; n = 14).
All animal experiments were carried out in accordance with the
Directive 2010/63/EU of the European Parliament and of the Council of
22 September 2010 on the protection of animals used for scientiﬁc
purposes and met the ARRIVE guidelines. The animal procedures were
approved by the Animal Experimentation Ethics Committee (AEEC) of
the University of Luxembourg (Project ID 15-SPM-01-UH) and the
“Ministère de l'Agriculture, de la Viticulture et de la Protection des
consommateurs".
2.2. Maternal separation (MS)
Maternal separation was carried out on at least four diﬀerent litters.
The day pups were ﬁrst seen was marked as P0. From P2 to P12 pups
were separated from the dam, placed on a heated pad at 33 °C (± 2 °C)
and left undisturbed for 3 h/day. At the end of each separation period
pups were returned to their home cage. No other manipulation was
done than indicated.
2.3. Chronic constriction injury (CCI) surgery
At two months of age, after baseline behavioral testing, rats un-
derwent the CCI surgery. They were deeply anaesthetized with iso-
ﬂurane (4.5% for induction, 2.0–2.2% for maintenance) during the
entire procedure using an anesthesia apparatus (Univentor 400, Zejtun,
Malta). The right sciatic nerve was exposed in the mid-thigh and three
natural chromic gut 4-0 (Stoelting Europe, Dublin, Ireland) loose li-
gatures were placed around the nerve at a distance of 1 mm. The muscle
layer was closed with 4-0 silk sutures and the skin layer with surgical
skin staples.
In case animals presented signs of autotomy in the course of the
experiments, they were immediately removed and sacriﬁced in order to
minimize their suﬀering. For this reason 2 CON+CCI and 3 MS+CCI
animals were sacriﬁced before the end of the neuropathy protocol and
their results were discarded.
2.4. Behavioral tests
Noxious mechanical and thermal thresholds were assessed in 54
male rats using the von Frey monoﬁlament test and the cold plate test
respectively. All behavioral tests were done in the morning between
8:00 and 12:00 a.m. During each session, animals were moved to the
experimentation room at least 1 h before the start of the experiments to
allow them to habituate to the environment. Rats underwent the von
Frey monoﬁlament test, followed by the cold plate test. Baseline
thresholds were assessed on three consecutive days prior to the CCI
surgery. To assess the impact of maternal separation on neuropathic
pain, the pain sensitivity was tested at days 4, 7, 10, 14, and 21 after the
CCI surgery.
2.4.1. Von Frey monoﬁlament test
To evaluate mechanical pain thresholds, animals were placed on a
metal wire mesh ﬂoor, covered by a Plexiglas chamber
(19.5 × 19.5 × 14 cm) and given at least 15 min to acclimate, until
exploratory activity ceased. Filaments (OptiHair, MarstockNervTest,
Germany) were applied perpendicularly on the mid-plantar region of
the hind paw and pressure was gradually increased until the deﬂection
point of the ﬁlament. Pain thresholds were determined with the as-
cending and descending method of limits with forces ranging from 8 to
256 mN. The threshold force was deﬁned as the ﬁrst ﬁlament evoking at
least a 40% response rate (two withdrawals out of ﬁve consecutive
applications). Both hind paws were tested three times in an alternative
order and the mean results were deﬁned as the respective thresholds.
Fig. 1. Experimental design. After birth (P0), rats were separated into 2 experimental
groups. The ﬁrst one was left undisturbed while the second underwent the maternal se-
paration (MS) procedure from postnatal day 2 (P2) to P12. At two months of age, the
animals in each of the two groups were either assigned to a non-operated group (CON
resp. MS) or to a group that underwent chronic constriction injury (CON+CCI resp. MS
+CCI). All four groups were then tested for noxious mechanical and cold thresholds three
days in a row to assess baseline values. At day 0, CCI was performed in the respective
groups (CON+CCI and MS+CCI) and further behavioral tests were performed in all of
the animals on days 4, 7, 10, 14 and 21. After the last testing, animals were sacriﬁced and
the L4-L5 segments of the spinal cord were removed for qPCR analysis of biochemical
markers. Two additional sets of animals in the CON+CCI and MS+CCI groups were
included to study changes in the expression of biochemical markers early after CCI sur-
gery. They did not undergo behavioral tests and were sacriﬁced 4 days post-CCI.
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Results were then normalized for each animal by computing the ratio of
ipsi- to contralateral side expressed in percent. Finally, data for each
group were averaged.
2.4.2. Cold plate test
This test was used to assess stress- and pain-related changes in
thermal thresholds. To avoid sensitization it was performed at least
30 min after the von Frey test. In order to establish a baseline, rats were
placed on the cold plate set at a temperature of 5 °C for maximally three
minutes (cut-oﬀ time). In each session, this procedure was repeated
three times with a ten minute interval. Lifting or licking the paw as well
as jumping are commonly considered as behavioral indicators of pain.
We selected the number of paw lifts as behavioral parameter for the
assessment of thermal thresholds since CCI-induced neuropathy pro-
duced pronounced limping and reduced the animal capacity to jump.
The mean values of the three cold plate tests were deﬁned as the score
of a session.
2.5. Reverse transcription and real-time qPCR
Rats were rapidly killed by decapitation under deep anesthesia
(isoﬂurane 4.5%). Levels L4/L5 of the spinal cord were harvested and
divided into ipsilateral-contralateral sides. Total RNA was extracted by
the acid guanidium–thiocyanate–phenol–chloroform method using
TRIzol® reagent (Life Technologies, Halle, Belgium). The aqueous phase
containing RNA was collected and precipitated with isopropanol. The
RNA pellet was washed with 70% ethanol, air dried, dissolved in Rnase
free water (VWR, Leuven, Belgium) and stored at −80 °C until further
analysis.
RNA quality was assessed with the Experion system or the Experion
Automated Electrophoresis Station (Bio-Rad Laboratories, Nazareth,
Belgium) using StdSens chips (Bio-Rad). The RNA quality indicator was
between 7 and 9. RNA concentration was measured using the Nanodrop
2000 spectrophotometer quantiﬁcation system (Isogen Life Sciences,
Netherlands). Reverse transcription was performed with the Improm-II
reverse transcription kit (Promega, Leiden, Netherlands) to convert
500 ng of total RNA into cDNA with 0.5 μg/ml of Oligo dT15 primer by
using a C1000 Touch thermocycler. qPCR experiments were carried out
on a CFX 96 real-time system (Bio-Rad, Nazareth, Belgium) with
12.5 ng of cDNA in a ﬁnal volume of 20 μl using PerfeCTa® SYBR® Green
SuperMix (VWR, Leuven, Belgium) containing 2X reaction buﬀer with
optimized concentrations of MgCl2, dNTPs, AccuStart Taq Polymerase,
SYBR Green I dye, stabilizers as well as forward and reverse primers at
2 μM. Primers were designed using Beacon Designer™ software, tested
for sequence speciﬁcity using the Basic Local Alignment Search Tool at
NCBI and validated on spinal cord (for list of primers used in the study,
see Table 1). The following protocol was used: polymerase activation at
95 °C for 3 min, 40 cycles of denaturation at 95 °C for 10 s and an-
nealing at 61 °C for 30 s. Finally, the melting curves were recorded
between 65 °C and 95 °C in 0.5 °C intervals. Each qPCR experiment was
run in triplicate and no-template controls were added as negative
controls. Threshold cycle values (Cq) were used to compute the amount
of target gene mRNA in relation to the reference gene mRNA (actin,
beta). ΔCq represents the diﬀerence between the number of cycles that
were necessary to detect the PCR products of the target genes and that
of the reference gene. ΔΔCq indicates the diﬀerence between the ΔCq of
the experimental groups (CON+CCI, MS and MS+CCI) and the ΔCq of
the control (CON) animals.
The data were expressed as 2-ΔΔCq and the mean of the right injured
side was computed for each group.
2.6. Statistical analysis
Data are presented as mean ± SEM. Homogeneity of variance was
tested using Levene's test or Shapiro-Wilk test. Statistical analysis for
the von Frey and the cold plate experiments was carried out using a
two-way (time x group) repeated measures analysis of variance
(ANOVA) followed by a Tukey's multiple comparison post hoc test to
check for diﬀerences between groups.
For all gene expression experiments, the ipsilateral spinal cord of
CON (no CCI) served as control and the relative expression level was set
to 1. The expression levels of the treatment groups CON+CCI 4d, CON
+CCI 21d, MS, MS+CCI 4d and MS+CCI 21d were expressed as fold of
CON. For statistical analysis, these relative expression levels (fold) were
Table 1
Sequences of primers used in this study.
Name
(gene)
Accession Sequence Amplicon size (bp)
Actin, beta NM_031144.3 F: 5′ GCT GAG AGG GAA ATC GTG CGT GAC 3′ 96
R: 5′ GGA GGA AGA GGA TGC GGC AGT GG 3′
GR
(NR3C1)
NM_012576.2 F: 5′ TGG AAA CCT GCT CTG CTT TG 3′ 102
R: 5′ GAG GAG ACA AAC AGC ATG TG 3′
NR1
(GRIN1)
NM_001270608.1 F: 5′ GGT TGC GTG GGC AAC ACC AA 3′ 80
R: 5′ CCG TCC GCA TAC TTA GAA GA 3′
NR2a
(GRIN2a)
NM_012573.3 F: 5′ CAG ATA ACA ATA AGA ACC ACA AG 3′ 83
R: 5′ AAC ATC GCT ACA GTC CTT 3′
NR2b
(GRIN2b)
NM_012574.1 F: 5′ AGG AAC CAG GCT ACA TCA AAA A 3′ 197
R: 5′ TAG TGA TCC CAC TGC CAT GTA G 3′
EAAT2
(Slc1a2)
NM_017215.2 F: 5′ ATG CTC CTC ATT CTC ACA G 3′ 103
R: 5′ CTA CAT TGA CCG AAG TTC TC 3′
EAAT3
(Slc1a1)
NM_013032.3 F: 5′ TCA TAG TCG TGC GGA AGA AC 3′ 111
R: 5′ AGC GGA ATG TAA CTG GAA GG 3′
GFAP NM_017009.2 F: 5′ TAC AGG AAA TTG CTG GAG GG 3′ 104
R: 5′ GAC ACA GAT TTG GTG TCC AG 3′
Iba1
(AIF 1)
NM_017196.3 F: 5′ AAT GAT GCT GGG CAA GAG AT 3′ 129
R: 5′ ACC TCC AAT TAG GGC AAC TC 3′
IL-1β NM_031512.2 F: 5′ AGA GTG TGG ATC CCA AAC AA 3′ 105
R: 5′ GGA ACT GTG CAG ACT CAA AC 3′
IL-6 NM_012589.2 F: 5′ CCA GAG TCA TTC AGA GCA ATA C 3′ 116
R: 5′ CTT CTC CAT TAG GAG AGC AT 3′
GDNF NM_019139.1 F: 5′ GTG TTG CTC CAC ACC GCG TCT 3′ 73
R: 5′ GGT CTT CGG CGG GCG CTT C 3′
NGF NM_001277055.1 F: 5′ CAC GGA CAT CAA GGG CAA GGA 3′ 96
R: 5′ GCT CGG CAC TTG GTC TCA AA 3′
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compared using a two-way (stress x CCI) ANOVA with Tukey's multiple
comparison post hoc test.
A summary of the statistical analysis is given in Table 2.
3. Results
3.1. Eﬀect of MS and CCI surgery on pain-related behavior
3.1.1. Mechanical pain threshold
Baseline mechanical thresholds were assessed in all four groups
before performing CCI-surgery in the respective groups at d0 (Fig. 2A).
No signiﬁcant diﬀerences could be found between groups (CON:
103.27 ± 5.65; CON+CCI: 94.68 ± 4.20; MS: 99.29 ± 5.30; MS
+CCI: 96.61 ± 4.00), indicating that MS per se had no eﬀect on me-
chanical pain threshold. This was true for the entire period of testing in
which the MS group did not present any signiﬁcant diﬀerences as
compared to CON (d4: CON 101.94 ± 5.08, MS 101.18 ± 5.46; d7:
CON 104.44 ± 6.34, MS 108.46 ± 4.91; d10: CON 100.15 ± 6.61,
MS 96.23 ± 3.83; d14: CON 94.48 ± 6.04, MS 99.96 ± 2.66; d21:
CON 105.41 ± 5.98, MS 111.22 ± 8.32).
As expected, CCI-surgery resulted in a decrease of mechanical
thresholds in CON+CCI and MS+CCI groups. In CON+CCI the
threshold constantly dropped until d14 and then started to recover on
d21 (d4: 71.12 ± 10.22; d7: 46.94 ± 7.83; d10: 41.85 ± 5.82; d14:
24.32 ± 2.05; d21: 42.14 ± 6.47). When compared to CON this
decrease turned out to be signiﬁcantly diﬀerent at d4 (p < 0.01) and
highly signiﬁcant from d7 on (p < 0.001). The reduction of mechan-
ical thresholds observed in MS+CCI animals did not display a parallel
time course. Pain thresholds slowly but constantly decreased until the
end of the experiment at d21 without showing recovery (d4:
93.98 ± 9.16; d7: 77.18 ± 5.44; d10: 78.21 ± 7.50; d14:
59.51 ± 9.95; d21: 43.86 ± 7.04). When comparing to the group
only exposed to MS, signiﬁcant diﬀerences were found for all time
points (d4: p < 0.05, d7: p < 0.01, d14: p < 0.001, d21:
Table 2
Analysis of variance (ANOVA) - summary of F-values of the behavioral (two-way, re-
peated measures) and biochemical (two-way) studies.
Two-way repeated measures ANOVA
interaction time group
Von Frey test F(15,225) = 6.84 F(5,225) = 13.09 F(3,45) = 41.88
Cold plate test F(15,225) = 14.38 F(5,225) = 26.09 F(3,45) = 33.25
p < 0.0001 for all values
Two-way ANOVA
interaction CCI stress
GR F(2,37) = 1.195
P = 0.3141
F(2,37) = 26.35
P < 0.0001
F(1,37) = 0.4873
P = 0.4895
NR1 F(2,36) = 8.798
P = 0.0008
F(2,36) = 0.9035
P = 0.4145
F(1,36) = 13. 78
P = 0.0007
NR2a F(2,36) = 9.486
P = 0.0005
F(2,36) = 8.985
P = 0.0007
F(1,36) = 17.45
P = 0.0002
NR2b F(2,37) = 1.896
P = 0.1645
F(2,37) = 2.397
P = 0.1050
F(1,37) = 19.47
P < 0.0001
EAAT2 F(2,36) = 0.7511
P = 0.4791
F(2,36) = 20.60
P < 0.0001
F(1,36) = 5.740
P = 0.0219
EAAT3 F(2,36) = 11.14
P = 0.0002
F(2,36) = 8.542
P = 0.0009
F(1,36) = 44.50
P < 0.0001
Iba1 F(2,36) = 1.013
P = 0.3734
F(2,36) = 47.00
P < 0.0001
F(1,36) = 14.23
P = 0.0006
GFAP F(2,36) = 2.701
P = 0.0807
F(2,36) = 6.238
P = 0.0047
F(1,36) = 6.033
P = 0.0190
IL-1β F(2,36) = 3.310
P = 0.0479
F(2,36) = 11.87
P = 0.0001
F(1,36) = 5.701
P = 0.0223
IL-6 F(2,36) = 3.259
P = 0.0500
F(2,36) = 24.10
P < 0.0001
F(1,36) = 0.9615
P = 0.3334
GDNF F(2,36) = 4.952
P = 0.0126
F(2,36) = 1.895
P = 0.1651
F(1,36) = 6.573
P = 0.0147
NGF F(2,36) = 23.18
P < 0.0001
F(2,36) = 0.0808
P = 0.9225
F(1,36) = 0.02879
P = 0.8662
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Fig. 2. Maternal separation stress reduces CCI-induced mechanical and cold hypersensi-
tivity. (A) Mechanical pain thresholds were measured by the Von Frey test before and
during the 21 days of neuropathy and expressed as percent ratio of ipsi- to contralateral
side. Before induction of CCI, all four groups presented similar mechanical thresholds.
The control (CON, black circles) and the maternally separated group (MS, black triangles)
were not subjected to CCI; their mechanical threshold was unchanged in the course of the
experiment. In the control group that underwent CCI surgery (CON+CCI, white circles)
the mechanical pain threshold decreased until day 14 and started to recover at day 21.
The maternally separated group that was subjected to CCI (MS+CCI, white triangles)
reacted with a steady decrease of pain thresholds until the end of the experiment. MS
+CCI animals were less sensitive than the CON+CCI group for up to 14 days. (B)
Thermal pain thresholds were evaluated by using the cold plate test. The number of lifts
of the ipsilateral (right) paw was recorded before and up to 21 days after induction of CCI.
No paw lifts could be observed in the baseline testing of all four groups before CCI sur-
gery. The two groups, CON (black circles) and MS (black triangles), that were not exposed
to neuropathic pain remained insensitive to cold stimuli throughout the testing period.
Control animals undergoing CCI surgery (CON+CCI, white circles) rapidly developed a
pronounced cold allodynia that steadily increased until the end of the experiment at day
21. Rats with a history of early life stress that were exposed to neuropathic pain (MS
+CCI, white triangles), exhibited a slight but insigniﬁcant increase in cold sensitivity
during the ﬁrst 10 days of the testing period and exhibited signiﬁcant cold allodynia only
in the late phase of CCI at d14 and d21. Data are expressed as mean ± SEM per group per
day. * represents a signiﬁcant diﬀerence between CON and CON+CCI or MS and MS
+CCI for the individual time point (*p < 0.05, **p < 0.01, ***p < 0.001). # indicates
a signiﬁcant diﬀerence between CON+CCI and MS+CCI (#p < 0.05, ##p < 0.01,
###p < 0.001).
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p < 0.001).
Animals with a history of maternal separation (MS+CCI) exhibited
a clearly higher mechanical threshold after induction of neuropathic
pain than rats that were not subjected to this early life stress (CON
+CCI). Shortly after CCI surgery at d4, a signiﬁcant diﬀerence
(p < 0.05) between the two groups could already be seen. From d7 to
d14, the diﬀerence between groups was pronounced (d7: p < 0.01;
d10 and d14: p < 0.001). At d21 the mechanical thresholds of CON
+CCI and MS+CCI groups became comparable again.
Taken together, these results indicate that MS protracts the ap-
pearance of mechanical hyperalgesia associated with neuropathy.
3.1.2. Thermal pain threshold
As described for the assessment of baseline mechanical thresholds,
the thermal sensitivity was measured in the four experimental groups
prior to CCI on d0 (Fig. 2B). No signiﬁcant diﬀerences in the number of
paw lifts were observed between the groups (CON: 0.03 ± 0.02, CON
+CCI: 0.00, MS: 0.00, MS+CCI: 0.00). The thermal sensitivity of CON
and MS animals remained constantly low throughout the experiment;
the two groups did not display any signiﬁcant diﬀerences.
CCI surgery in the CON+CCI and MS+CCI groups resulted in a
decrease of nociceptive thermal thresholds. The rise in paw lifts was
much more pronounced in the CON+CCI animals and steadily in-
creased throughout the experiment until d21 (d4: 5.82 ± 0.66, d7:
5.21 ± 0.94, d10: 8.68 ± 1.64, d14: 10.77 ± 1.85, d21:
11.56 ± 1.73). The comparison with its control CON yielded a high
statistical signiﬁcance (p < 0.001) for all time points. In MS+CCI the
number of paw lifts slightly increased after induction of neuropathy
(d4: 1.71 ± 0.64, d7: 2.14 ± 0.70, d10: 2.17 ± 0.92) without
gaining statistical signiﬁcance when comparing to the MS group. From
d14 on the thermal sensitivity further increased reaching a signiﬁcant
level (d14: 2.53 ± 0.73, p < 0.05; d21: 4.43 ± 0.74, p < 0.001).
Rats that underwent early life stress (MS+CCI) developed clearly less
thermal hyperalgesia under conditions of neuropathic pain than ani-
mals that grow up normally (CON+CCI). This diﬀerence could already
be seen early after induction of CCI and lasted until the end of the
experiment. Statistical tests revealed signiﬁcances between the two
groups of p < 0.01 for d4, p < 0.05 for d7 and p < 0.001 for d10,
d14 and d21. Altogether these results suggest that animals that were
subjected to MS present reduced and delayed development of thermal
hyperalgesia in neuropathic pain states.
3.2. Impact of early life stress and neuropathic pain on the expression of
spinal biochemical markers
3.2.1. Glucocorticoid receptor regulation
CON and MS presented comparable GR mRNA levels (1.03 ± 0.25
and 1.16 ± 0.16 resp.) (Fig. 3A), suggesting that maternal separation
stress per se did not aﬀect the expression of the glucocorticoid receptor.
The induction of CCI resulted in a signiﬁcant downregulation of GR
mRNA at d4 in CON+CCI (0.72 ± 0.11; p < 0.01 compared to CON)
as well as in MS+CCI rats (0.72 ± 0.41; p < 0.001 compared to MS).
At a later state of neuropathy, on d21, GR mRNA expression returned to
normal levels in the CON+CCI group (1.02 ± 0.85; p < 0.001 to
CON+CCI 4d) and in MS+CCI animals (0.99 ± 0.09; p < 0.001 to
MS+CCI 4d). The two-way ANOVA revealed signiﬁcant main eﬀects
only for CCI, not for stress or interaction (Table 2).
3.2.2. Regulation of glutamate receptors and transporters
In comparison to CON, MS per se signiﬁcantly increased the mRNA
expression of all three examined subunits of the NMDA receptor, NR1
(CON: 1.01 ± 0.07, MS: 1.60 ± 0.06; p < 0.05), NR2a (CON:
1.01 ± 0.09, MS: 1.65 ± 0.05; p < 0.001) and NR2b (CON:
1.07 ± 0.15, MS: 1.54 ± 0.06; p < 0.01) (Fig. 3B, 3C, 3D).
In the initial post-surgical phase, at d4, CCI had no inﬂuence on the
mRNA levels of NR1 (1.12 ± 0.08), NR2a (1.08 ± 0.6) and NR2b
(0.99 ± 0.1) in CON+CCI rats. In contrast, MS+CCI animals reacted
with a signiﬁcant decrease of NR1 (1.07 ± 0.11; p < 0.05 to MS) and
NR2a (0.94 ± 0.07; p < 0.001 to MS) mRNA levels and a clear
tendency to reduced mRNA expression in NR2b (1.15 ± 0.17) at this
time point, now being comparable to CON+CCI.
At post-CCI day 21, animals from the CON+CCI group presented a
trend to reduced NR1 (0.78 ± 0.05; n.s. to CON, but p < 0.01 to CON
+CCI 4d) and signiﬁcantly decreased NR2a levels (0.74 ± 0.06;
p < 0.05 to CON), but no signiﬁcant change in NR2b (0.86 ± 0.05)
mRNA expression.
In MS+CCI animals a tendency to recover could be observed on
d21. The mRNA levels of all three subunits increased slightly (NR1:
1.24 ± 0.17, NR2a: 1.19 ± 0.21, NR2b: 1.43 ± 0.15), returning
nearly to basal values, except for NR2a which was still signiﬁcant dif-
ferent from MS (p < 0.05). Nevertheless, for NR1, NR2a and NR2b a
signiﬁcant diﬀerence (p < 0.01, p < 0.05 and p < 0.01 resp.) to the
CON+CCI group could be assessed. Generally, signiﬁcant main eﬀects
were revealed for stress (NR1, NR2a, NR2b), CCI (NR2a) and interac-
tion (NR1, NR2a) (Table 2).
EAAT2 mRNA levels did not signiﬁcantly diﬀer between non-in-
jured CON and MS animals (CON: 1.02 ± 0.1; MS: 0.93 ± 0.48)
(Fig. 3E). Post-CCI, at d4, CON+CCI and MS+CCI groups presented a
similar and signiﬁcant reduction of EAAT2 mRNA levels when com-
pared to the respective controls (CON+CCI: 0.67 ± 0.03, p < 0.001
to CON; MS+CCI: 0.63 ± 0.04, p < 0.01 to MS). In the later phase of
the neuropathic state, at d21, EAAT2 mRNA levels of CON+CCI re-
turned approximately to basal values (0.89 ± 0.05), thus being no
longer signiﬁcantly diﬀerent from CON, but remaining diﬀerent from
CON+CCI at d4 (p < 0.001). In the same line the EAAT2 mRNA ex-
pression in MS+CCI animals slightly increased at d21 (0.73 ± 0.05),
leading also to a loss of signiﬁcant diﬀerence to MS.
Regarding EAAT3, early life stress had a clear impact on the mRNA
expression (Fig. 3F). The mRNA level increased to 1.38 ± 0.01 in MS
and was hence signiﬁcantly higher than seen in CON (1.00 ± 0.03;
p < 0.001). Induction of neuropathic pain had no eﬀect on the CON
+CCI group at d4 (1.13 ± 0.06), but led to a signiﬁcant decrease of
EAAT3 mRNA levels in the maternally separated animals MS+CCI
(1.13 ± 0.06; p < 0.01 to MS), that now were similar to CON+CCI.
At d21 post-surgery the EAAT3 mRNA level dropped in the CON+CCI
group (0.8 ± 0.05; n.s. to CON but p < 0.001 to CON+CCI 4d),
whereas the level slightly increased in the MS+CCI animals
(1.20 ± 0.06), thus being no longer signiﬁcantly diﬀerent from MS.
The small downregulation in CON+CCI 21d and the minor upregula-
tion in MS+CCI 21d ﬁnally resulted in a highly signiﬁcant diﬀerence
between these two groups (p < 0.001). Signiﬁcant main eﬀects were
obtained for stress (EAAT2, EAAT3), CCI (EAAT2, EAAT3) and inter-
action (EAAT3) (Table 2).
3.2.3. Glial cell activation
The expression of Iba1 (ionized calcium-binding adaptor protein-1)
mRNA in microglia was aﬀected by early life stress (Fig. 4A). The MS
group exhibited a signiﬁcantly reduced mRNA level (0.74 ± 0.01) as
compared to CON (1.00 ± 0.05; p < 0.05). Shortly after CCI surgery,
the Iba1 mRNA expression signiﬁcantly increased in the CON+CCI
(2.69 ± 0.08; p < 0.001 to CON) as well as in the MS+CCI group
(1.84 ± 0.14; p < 0.001 to MS). The diﬀerence between the two
groups did stay statistically signiﬁcant (p < 0.05), as seen between
CON and MS. At the early chroniﬁcation phase of neuropathic pain
(d21), the Iba1 mRNA level decreased in the CON+CCI group
(1.84 ± 0.03; p < 0.001 to CON+CCI 4d) and was still signiﬁcantly
diﬀerent from the basal level in CON (p < 0.01). The expression in the
MS+CCI group, did however not change as compared to d4 and hence
remained signiﬁcantly diﬀerent from the non-injured MS (p < 0.01).
At this time point the diﬀerence between CON+CCI and MS+CCI be-
came smaller and lost signiﬁcance. In summary, maternal separation
stress led to a decrease of microglia activation under normal conditions
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(no neuropathy) and to a reduced upregulation of Iba1 mRNA under
CCI conditions.
In contrast to the upregulation of the microglia marker Iba1 ob-
served in animals subjected to early life stress, MS per se had no impact
on the mRNA expression of the astrocytic marker GFAP (glial ﬁbrillary
acidic protein) (CON: 1.03 ± 0.11, MS: 1.07 ± 0.06) (Fig. 4B). CCI
led to a statistically signiﬁcant upregulation of GFAP mRNA in CON
+CCI at d4 post-surgery (1.43 ± 0.08; p < 0.05 to CON), but not in
A
No CCI CCI 4d CCI 21d
R
el
at
iv
e 
E
xp
re
ss
io
n 
le
ve
l (
fo
ld
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
**
###
*
##
GR
CON
MS
No CCI CCI 4d CCI 21d 
0.0
0.5
1.0
1.5
2.0
R
el
at
iv
e 
E
xp
re
ss
io
n 
le
ve
l (
fo
ld
) *
**
NR1
B
No CCI CCI 4d CCI 21d
0.0
0.5
1.0
1.5
2.0
R
el
at
iv
e 
E
xp
re
ss
io
n 
le
ve
l (
fo
ld
) ***
#
###
NR2a
C D
No CCI CCI 4d CCI 21d
0.0
0.5
1.0
1.5
2.0
**
R
el
at
iv
e 
E
xp
re
ss
io
n 
le
ve
l (
fo
ld
)
NR2b
No CCI CCI 4d CCI 21d
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
R
el
at
iv
e 
E
xp
re
ss
io
n 
le
ve
l (
fo
ld
)
### ##
*
EAAT2
E
No CCI CCI 4d CCI 21d 
R
el
at
iv
e 
ex
pr
es
si
on
 le
ve
l (
fo
ld
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
*** ***
***##
EAAT3
F
**
#
*
#
Fig. 3. Regulation of actors of spinal glutamatergic synapse function. Gene expression in the spinal cord was examined for the glucocorticoid receptor (GR) (A), the NMDA receptor
subunits NR1 (B), NR2a (C), NR2b (D) and the glutamate transporters EAAT2 (E) and EAAT3 (F). Mean mRNA levels where assessed in control (CON, black bars) and maternally
separated animals (MS, white bars) under three diﬀerent conditions: without CCI surgery (no CCI), CCI lasting four days (CCI 4d) and CCI lasting 21 days (CCI 21d). (A) GR expression did
not diﬀer between CON and MS animals in the three conditions. GR mRNA was downregulated at 4 days after induction of CCI and recovered in the late phase at 21 days. (B–D) The three
NMDA receptor subunits followed a similar regulation scheme: mRNA upregulation in MS animals per se, downregulation in MS 4 days after CCI but no change in CON, and slight
reduction in CON after 21 days of CCI when MS started to recover. (E, F) The regulation of mRNA expression was diﬀerent in the glial EAAT2 and the neuronal EAAT3 transporter. The
level of EAAT2 mRNA did not diﬀer between CON and MS under the three diﬀerent conditions CCI surgery downregulated EAAT2 mRNA at 4d followed by a recovery trend at 21d. The
regulation of EAAT3 mRNA resembles the scheme seen for the NMDA subunits: upregulation in MS per se, downregulation in MS 4 days after CCI but no change in CON, and slight
recovery in MS but downregulation in CON after 21 days of CCI. Data are expressed as relative expression level (fold) of “CON, no CCI” (=1) and are shown as mean ± SEM. # represents
a signiﬁcant diﬀerence between “CON, no CCI” and “CON+CCI 4d” or “CON+CCI 21d” or between “MS, no CCI” and “MS+CCI 4d” or “MS+CCI 21d” (#p < 0.05, ##p < 0.01,
###p < 0.001). * indicates a signiﬁcant diﬀerence between groups for other comparisons than the ones covered by # (*p < 0.05, **p < 0.01, ***p < 0.001).
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the MS+CCI group (1.24 ± 0.9). Nevertheless, the diﬀerence between
the CON+CCI and the MS+CCI groups did not reach statistical sig-
niﬁcance in the early phase of neuropathy. Later on, at d21, the GFAP
mRNA stayed upregulated in the CON+CCI animals (1.44 ± 0.07;
p < 0.05 to CON) and the MS+CCI group remained unaﬀected by the
surgery (1.09 ± 0.08). In this state, a signiﬁcant diﬀerence between
the two groups could be observed (p < 0.05). Taken together, MS
prevented the upregulation of GFAP mRNA triggered by CCI. The two-
way ANOVA revealed signiﬁcant main eﬀects for stress and CCI for Iba1
as well as for GFAP (Table 2).
3.2.4. Regulation of pro-inﬂammatory cytokines
The IL-1β mRNA expression was slightly, but not signiﬁcantly re-
duced in MS per se (CON: 1.02 ± 0.12, MS: 0.77 ± 0.04) (Fig. 4C). On
post-CCI day 4, IL-1β mRNA was clearly upregulated in CON+CCI
(2.69 ± 0.82; p < 0.01 to CON) but only a tendency to higher levels
was observed in MS+CCI animals (1.15 ± 0.13), leading to a sig-
niﬁcant diﬀerence between the two groups (p < 0.05). The IL-1β
mRNA level started to decrease in CON+CCI animals at d21 after CCI
surgery (1.79 ± 0.08; n.s. to CON and n.s. to CON+CCI 4d) but
further increased in MS+CCI (1.83 ± 0.25; p < 0.01 to MS), re-
sulting in the loss of a signiﬁcant diﬀerence between the CON+CCI and
MS+CCI group. The data do hence suggest that the early life stress
tended to decrease the expression of IL-1β under normal conditions,
and particularly delayed the upregulation seen in neuropathic states.
Statistical signiﬁcant main eﬀects were obtained for stress, CCI and
interaction (Table 2).
Regarding the IL-6 mRNA expression, no diﬀerence was found be-
tween CON (1.01 ± 0.9) and MS (1.17 ± 0.09). Four days after in-
duction of CCI the IL-6 mRNA level increased considerably in CON
+CCI (12.59 ± 1.44; p < 0.001 to CON) and in MS+CCI
(8.28 ± 1.50; p < 0.01 to MS). Although the CON+CCI and MS+CCI
groups respectively presented a 12 fold and an 8 fold increase of IL-6
mRNA levels, this diﬀerence did not turn out to be statistically sig-
niﬁcant due to high levels of variance in the two groups. In the later
phase of the experiment, at d21, the IL-6 mRNA levels decreased sig-
niﬁcantly for CON+CCI (4.08 ± 0.59; p < 0.001 to CON+CCI 4d)
and also dropped in MS+CCI (5.98 ± 0.55) being no longer sig-
niﬁcantly diﬀerent from CON resp. MS. The statistical analysis revealed
that animals with a history of maternal separation did not display any
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Fig. 4. Regulation of markers of spinal immunocompetent cell activation and of pro-inﬂammatory cytokines. Gene expression in the spinal cord was examined for the microglial marker
Iba1 (A), the astroglial marker GFAP (B) and the pro-inﬂammatory cytokines IL-1β (C) and IL-6 (D). Mean mRNA levels where assessed in control (CON, black bars) and maternally
separated animals (MS, white bars) under three diﬀerent conditions: without CCI surgery (no CCI), CCI lasting four days (CCI 4d) and CCI lasting 21 days (CCI 21d). (A) Iba1 mRNA levels
were downregulated in MS as compared to CON. Induction of CCI upregulated the gene expression at 4d in both groups, the signiﬁcant diﬀerence between groups remained. A beginning
recovery could be observed at d21 in CON and a tendency to recover in MS. (B) GFAP mRNA levels did not diﬀer between “CON, no CCI” and “MS, no CCI”. Neuropathy surgery
upregulated the gene expression only in “CON+CCI 4d and 21d” but not in MS. (C) IL-1β mRNA expression tended to be lower in “MS, no CCI” as compared to “CON, no CCI”. After
induction of CCI at d4, IL-1β was quickly upregulated in CON and started to increase in MS. Later, at day 21, the IL-1βmRNA level already decreased in CON whereas it further increased
in MS. (D) IL-6 mRNA levels did not signiﬁcantly diﬀer between CON and MS in all three conditions. The gene expression was highly upregulated in CON and MS 4 days after CCI surgery.
Under long-term neuropathy conditions, mRNA levels decreased coming close to normal expression rates. Data are expressed as relative expression level (fold) of “CON, no CCI” (=1) and
are shown as mean ± SEM. # represents a signiﬁcant diﬀerence between “CON, no CCI” and “CON+CCI 4d” or “CON+CCI 21d” or between “MS, no CCI” and “MS+CCI 4d” or “MS
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diﬀerences in IL-6 mRNA levels as compared to the respective controls.
A signiﬁcant main eﬀect was only found for CCI (Table 2).
3.2.5. Expression of neurotrophins
MS per se did not modify GDNF mRNA levels (CON: 1.01 ± 0.07,
MS 1.15 ± 0.11) (Fig. 5A). The induction of neuropathic pain had no
signiﬁcant inﬂuence on the expression of GDNF mRNA in CON+CCI
animals (0.94 ± 0.10) early after surgery at d4, however a reduction
could be observed in MS+CCI (0.88 ± 0.04; p < 0.05 to MS). After
21 days of injury, a signiﬁcant decrease of the GDNF mRNA level took
place in the CON+CCI group (0.79 ± 0.03; p < 0.05 to CON),
whereas animals with a history of early life stress reacted with an in-
crease of this neurotrophin mRNA (1.20 ± 0.10; p < 0.01 to MS
+CCI 4d) at this time point, ending up with an mRNA level numerically
above but not signiﬁcantly diﬀerent to MS. However, in this late phase
of neuropathy, a signiﬁcant diﬀerence was obtained when comparing
CON+CCI and MS+CCI (p < 0.01). Statistically signiﬁcant main
eﬀects were obtained for stress and interaction (Table 2).
The baseline NGF gene expression was comparable between the
CON (1.15 ± 0.62) and MS (1.01 ± 0.08) group (Fig. 5B). Four days
following CCI surgery, NGF mRNA levels increased in CON+CCI
(1.36 ± 0.06; p < 0.05 to CON) and decreased in MS+CCI
(0.79 ± 0.07, p < 0.05 to MS) resulting in a highly signiﬁcant dif-
ference between the two groups (p < 0.001). After 21 days, both
groups roughly returned to control levels (CON+CCI: 0.85 ± 0.07;
p < 0.001 to CON+CCI 4d; MS+CCI: 1.26 ± 0.10, p < 0.01 to MS
+CCI 4d) but remained signiﬁcantly diﬀerent from each other
(p < 0.01). A signiﬁcant main eﬀect was obtained for interaction
(Table 2).
4. Discussion
The present study shows that early life stress related to MS in ro-
dents does not aﬀect basal thermal and mechanical nociceptive
thresholds per se but has a protective eﬀect on both modalities under
neuropathic conditions. This behavioral change was accompanied by
molecular alterations in the spinal cord. To our knowledge the impact
of MS on mediators involved in the spinal processing of neuropathic
pain has not been studied so far.
4.1. Maternal separation reduces CCI-induced hyperalgesia/allodynia
In humans, adverse early life events are associated with enhanced
risks of developing mental or physical health problems including
chronic pain disorders later in life (Heim et al., 2010; Heim and Binder,
2012; Lupien et al., 2009). This has been shown to be related to a
permanent alteration of the hypothalamo-pituitary-adrenal (HPA) axis
(Sapolsky and Meaney, 1986), as well as of neural (Lippmann et al.,
2007; Mintz et al., 2005; Rana et al., 2014) and immune functioning
(Bilbo and Schwarz, 2009; Carpenter et al., 2010; Wieck et al., 2013). In
rodents, normal development during the critically vulnerable stress
hyporesponsive period (SHRP) in the ﬁrst two post-natal weeks essen-
tially depends on maternal care (Caldji et al., 1998). Disruption by
prolonged and/or repeated sequences of MS leads to alterations com-
parable to those observed in humans (Schmidt, 2010). Furthermore, the
ﬁrst week of the rodent's life corresponds developmentally to the third
trimester of human gestation (Lupien et al., 2009) making MS an ade-
quate model for the stress premature infants are exposed to.
In rats, early life stress has been associated with an attenuation of
drug-induced analgesic eﬀects (Dickinson et al., 2009; Kalinichev et al.,
2001), increased pain sensitivity in normal conditions (Alvarez et al.,
2013; Green et al., 2011) but also in the framework of several experi-
mental and clinical pain states such as chronic bowel syndrome
(O'Mahony et al., 2009), visceral hyperalgesia (Chung et al., 2007;
Tsang et al., 2012) and neuropathic pain (Zeng et al., 2008). While rats
undergoing early life stress have mostly been reported to present in-
creased nociceptive responses to mechanical and/or thermal nocicep-
tive stimulation (Chung et al., 2007; Tsang et al., 2012; Uhelski and
Fuchs, 2010), we did not observe any change in basal nociceptive
thresholds, but a reduced CCI-induced hypersensitivity for both mod-
alities. It should be noted here that MS does not in every case lead to the
development of psychiatric diseases (Rana et al., 2014) or enhanced
pain sensitivity (Weaver et al., 2007) later in life. Resilience, an
adaptive process allowing physiological (homeostatic) and behavioral
adaptation to stress, has also been observed in rodent models of early
life stress such as MS (Macrì et al., 2011). Pfau et Russo (2015) propose
that the resilience observed in rodents undergoing early life stress fol-
lows a U-shaped curve. Exposure to a medium amount of stress could
hence lead to resilience while very low or very high levels would lead to
vulnerability. It should be noted here that the term “resilience” is
generally considered to represent a positive adaptation of stress pro-
cessing to a context speciﬁc stressor while “vulnerability” is commonly
used to describe stress-related alterations in susceptibility to health
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Fig. 5. Regulation of spinal neurotrophins. Spinal gene expression was examined for the
neurotrophins GDNF (A) and NGF (B). Mean mRNA levels where assessed in control
(CON, black bars) and maternally separated animals (MS, white bars) under three dif-
ferent conditions: without CCI surgery (no CCI), CCI lasting four days (CCI 4d) and CCI
lasting 21 days (CCI 21d). (A) GDNF mRNA expression did not diﬀer between CON and
MS under the conditions of no CCI and CCI 4d. In the long-term CCI condition, GDNF
mRNA level diﬀered between CON and MS, due to an upregulation in MS animals. (B)
NGF mRNA levels were not diﬀerent in “CON, no CCI” and “MS, no CCI” animals. The
induction of CCI triggered an increase in CON and a decrease in MS 4 days post-surgery.
At d21, a recovery occurred, which partly overshoot and consequently resulted in a dif-
ference in mRNA expression between CON and MS. Data are expressed as relative ex-
pression level (fold) of “CON, no CCI” (=1) and are shown as mean ± SEM. # represents
a signiﬁcant diﬀerence between “CON, no CCI” and “CON+CCI 4d” or “CON+CCI 21d”
or between “MS, no CCI” and “MS+CCI 4d” or “MS+CCI 21d” (#p < 0.05,
##p < 0.01). * indicates a signiﬁcant diﬀerence between groups for other comparisons
than the ones covered by # (**p < 0.01, ***p < 0.001).
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disorders like chronic pain syndromes later in life (Alvarez et al., 2013).
The fact that early life stress leads to alterations of brain structures is
involved both in stress and in pain processing (Prusator and
Greenwood-Van Meerveld, 2016) may impede a clear diﬀerentiation
between these two terms. Hence, we suggest that MS could lead to a
form of resilience to CCI-induced hypersensitivity independently to its
eﬀects on vulnerability or resilience to further stress processing.
Furthermore, diﬀerences in methodology across studies such as
rearing of the dams could lead to diﬀerences in experimental outcomes.
Transportation from the animal supplier to the client is a routine
practice but the stress induced by the shipping is rarely considered.
Despite the few studies investigating the implications of the shipping in
stress paradigms, increased blood corticosterone levels, decrease of
social behavior and locomotor activity up to 16 days after transporta-
tion have been observed (Arts et al., 2012). These results suggest that
shipping can have long lasting physiological and behavioral eﬀects.
This would especially be true for developmental and high plasticity
periods such as gestation (Lupien et al., 2009; Weinstock, 2008).
Nevertheless, several studies showing an increased sensitivity following
early life stress were performed in the oﬀspring of females that were
pregnant at the time point of shipment (Alvarez et al., 2013; Chung
et al., 2007; Green et al., 2011; Kalinichev et al., 2001; Nishinaka et al.,
2016; Tsang et al., 2012). The animals to be tested could hence have
accumulated pre- and post-natal stress. Variations in experimental
outcomes could thus at least partly be related to our rearing the dams in
our facility.
4.2. MS alters spinal glutamatergic transmission and transport
The glucocorticoid receptor (GR) is a key regulator of the amplitude
of the HPA response to stressors (Strüber et al., 2014) and of neuro-
pathy-induced plastic changes (Wang et al., 2004, 2005, 2006). In the
present study we observed that spinal GR expression was not diﬀerent
between CON and MS groups, neither under basal conditions, nor
shortly (4d) and later (21d) after the CCI surgery. There is a paucity of
studies investigating the impact of circulating corticosterone on spinal
GR expression and to our knowledge no study has explored the impact
of chronic stress on spinal GR expression. However, Patacchioli et al.
(1998) showed no eﬀect of 21 days of corticosterone treatment on
spinal GR mRNA. Therefore, it is diﬃcult to establish a parallel between
our spinal GR mRNA results and a hypothetical HPA axis alteration by
MS. In our hands only CCI had an impact on GR mRNA expression le-
vels. Indeed, CON and MS groups presented a decrease of GR expression
4 days after CCI and recovered after 21 days. CCI-induced reduction of
GR expression was not expected since Wang and collaborators (2004,
2005, 2006) reported that CCI induced a time-dependent increase of GR
protein and mRNA expression parallel to the development of painful
behaviors. The pattern of expression found in CON and MS animals
following CCI could be due to injury-related pain and distress, where
the resulting hypothetical increase of corticosteroid concentration
might have been compensated by a decrease of GR expression. Subse-
quently, as the animals recovered from the injury, the GR mRNA ex-
pression returned to levels comparable to those of non-injured rats. The
ﬁnding that only MS rats displayed a strong increase of neuropathy-
related pain thresholds while both CON and MS animals presented si-
milar reduction of GR expression during the CCI phase may point to an
alternative CORT-dependent mechanism of pain inhibition potentially
emerging in the MS animals. In these rats, the production of spinal
neurosteroids might have enhanced GABAergic and hence inhibitory
transmission (Zell et al., 2015).
Since corticosterone may regulate glutamate receptors (Wang et al.,
2005) and transporters (Wang et al., 2006) through GR activation
under neuropathic pain conditions we investigated NMDA receptor and
transporter subunit mRNA expression levels.
Experimental neuropathic pain models resulted in enhanced NR1
and NR2 expression levels ipsilateral to injury (Abe et al., 2005; Wang
et al., 2005). We report a diﬀerential eﬀect of CCI on animals that
underwent MS as compared to CON. Although these results are not
directly indicative of spinal nociceptive transmission, the functional
properties of the NMDA receptor depend on patterns of subunit asso-
ciations reﬂecting enduring plastic changes in synaptic eﬃcacy. The
association of NR1 and NR2a subunits does e.g. provide a higher
opening probability, a reduced sensitivity to glutamate and a faster
decay of excitatory postsynaptic current (EPSC) than the NR1/NR2b
NMDA subunit association (Paoletti et al., 2013). This association has
been proposed to be, at least to some extent, responsible for the central
sensitization involved in the development of neuropathic pain (Wilson
et al., 2005; Wu and Zhuo, 2009). In adult male Wistar rats, a decay of
NR1 protein has previously been reported by Wilson et al. (2005) 16
days after CCI. In that study, the authors did not report a decrease of
NR2a but we cannot exclude the possibility that the decrease we ob-
served at post-CCI day 21 occurred after the 16th day post-CCI.
Whereas several studies suggest a primordial role of NR2b in the es-
tablishment and maintenance of neuropathic pain (Karlsson et al.,
2002; Wilson et al., 2005; Wu and Zhuo, 2009) we did not observe any
drastic change in the NR2a/NR2b ratio following CCI. MS animals
presented a general augmentation of all three NMDA receptor subunit
mRNA levels that would suggest an enhanced nociceptive transmission
and a resulting decrease of pain thresholds. Shortly after the CCI sur-
gery, NR1 and NR2a subunit mRNA expression seemed to decrease to a
larger extent than NR2b mRNA. This would suggest a change of NMDA
subunit proportions toward more NR1/NR2b association in MS animals.
Furthermore, 21 days after CCI NR1 and NR2b subunits expression
recovered to MS basal levels. The observation that MS+CCI rats
seemed to display a greater NR1/NR2b subunit association than CON
+CCI might indicate a mechanism underlying delayed development of
neuropathic allodynia/hyperalgesia in MS animals when compared to
CON.
Neuronal (EAAT3) and glial (EAAT2) glutamate transporters are
involved in nociceptive processing in healthy individuals since injection
of blockers elicits a dose-dependent spontaneous nociceptive behavior
(Liaw et al., 2005), but also in neuropathic animals since their protein
and mRNA expression are modiﬁed following CCI (Sung et al., 2003;
Wang et al., 2006). In the present study, MS animals presented higher
mRNA levels of EAAT3, but not EAAT2, suggesting an increased glu-
tamate re-uptake in MS and therefore a reduced spinal transmission of
noxious information. In association with the increase of NMDA receptor
subunit expression, this result could explain the lack of diﬀerence in
nociceptive thresholds between MS and CON animals. In CON, CCI
tended to decrease the EAAT3 mRNA expression 21 days after surgery.
A reduction of EAAT3 expression was also reported by Sung et al.
(2003) who proposed that this was due to a loss of primary aﬀerents
resulting from the CCI, considering that most of glutamate transporters
are located at presynaptic sites (Danbolt, 2001).
Concerning EAAT2, we and other investigators observed a de-
creased expression at 4 but not 21 days after CCI in CON animals
(Napier et al., 2012; Xin et al., 2009). It is probable that this recovery
was due to a compensatory mechanism aimed at re-establishing a
“normal” re-uptake of glutamate by glial cells. Furthermore, since glial
glutamate transporters are believed to account for 90% of glutamate
clearance in the CNS (Danbolt, 2001), this result could be in line with
the initiation of a possible recovery of a normal sensitivity observed at
post-CCI day 21 in CON animals. In agreement with Gosselin et al.
(2010), MS did not impact the EAAT2 expression in non-injured con-
ditions. Likewise EAAT2 mRNA expression followed a comparable
pattern in MS and CON animals 4 and 21 days after CCI. This lack of
group diﬀerences suggests that the EAAT2 glutamate transporter does
not considerably contribute to CCI-related alterations in mechanical
and thermal hypersensitivity as seen between CON and MS in our be-
havioral experiments.
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4.3. Glial activation is depressed in animals with early life stress history
Nerve injury is associated with a strong activation of glial cells
(Mika et al., 2013). This activation results in the release of pro-in-
ﬂammatory cytokines and growth factors involved in the establishment
of central sensitization and in the development of neuropathic pain
(Marchand et al., 2005). In this context microglia and astrocytes do not
seem to be engaged in a similar manner. Iba1 and GFAP were respec-
tively chosen as markers of microglia and astrocytes because they are
both constitutively expressed and their expression is increased upon
activation (Ito et al., 1998; McMahon et al., 2005), allowing us to
evaluate basal and MS- or CCI-related levels. The pronounced and im-
mediate microglia activation after injury (Tanga et al., 2004) is be-
lieved to play a more prominent role in the establishment of mechanical
hypersensitivity (Raghavendra et al., 2004). Our results showing a more
pronounced Iba1 mRNA expression 4 days after neuropathy followed by
a recovery to lower levels at 21 days are in agreement with previous
studies (Mika et al., 2010). However, since there is a delay between the
behavioral establishment of a signiﬁcant mechanical hyperalgesia and
allodynia and the qPCR-related ﬁndings, it seems plausible that we
could have missed the peak of microglia activation. Furthermore,
variability can occur due to diﬀerences in neuropathy models. Indeed, it
has been shown that the activation of immunocompetent cells may
partly depend on the location and type of the nerve lesion (Colburn
et al., 1999; Hu et al., 2007). MS animals presented lower microglia
activation than CON animals during normal and neuropathic condi-
tions. Despite an increase of Iba1 mRNA levels following CCI, microglial
activity seemed dampened in MS animals. This is consistent with the
higher mechanical threshold observed from day 7–14 after CCI. The
lack of diﬀerence in mechanical thresholds between CON+CCI and MS
+CCI animals 21 days after surgery could be another indication that
microglia was predominantly involved in the establishment of me-
chanical hypersensitivity but not in its maintenance. Astrocytic acti-
vation is weaker but long lasting (Mika et al., 2013). Maintenance of
neuropathic states may depend on this sustained activation. Our result
is consistent with the existing literature since the CON+CCI group
presented an early but mild GFAP mRNA level increase which was
sustained until post-CCI day 21. It is interesting to note that the as-
trocytic activation was also dampened in the MS+CCI group during
neuropathic pain.
Glial activation plays a capital role in neuropathic pain through the
release of pro-inﬂammatory cytokines (Ledeboer et al., 2005) and
neurotrophins (Li et al., 2003). We focused on the interleukins 1-beta
(IL-1β) and 6 (IL-6) due to their well-documented involvement in
neuropathic states. Upon nerve injury, IL-1β is released concomitantly
with the induction of allodynia and hyperalgesia through its actions on
NMDA and GABA currents (Kawasaki et al., 2008; Wolf et al., 2006). IL-
1β also induces the secretion of other inﬂammatory mediators such as
itself, IL-6, TNF-α or NGF therefore contributing to neuropathic pain
(Marchand et al., 2005).
CCI alone induced a clear increase of IL-1βmRNA levels 4 days after
the surgery and started to recover at 21 days. On the contrary, in MS the
onset and extent of this upregulation was delayed. IL-6 on the other
hand presented a similar expression pattern in CON and MS 4 and 21
days after induction of neuropathic pain.
It is interesting to note that, in concordance with the Iba1 and GFAP
expression results, MS had an overall dampening eﬀect on the regula-
tion of pro-inﬂammatory cytokines in the early phase of neuropathy,
but not later at the beginning state of chroniﬁcation. This could be of
importance because IL-1β and IL-6 increase are both associated with the
development of abnormal sensitivity during neuropathic pain due to
their capacity to enhance not only NMDA receptor currents but also
AMPA receptor-mediated post-synaptic potentials (Liu et al., 2013;
Schäfers and Sorkin, 2008). The MS-related dampened im-
munocompetent reactivity observed in our hands could explain the
enhanced thermal and mechanical thresholds of these animals seen
during the early neuropathic pain states. Although a longer observation
period of neuropathy may be required, these results seem to indicate
that MS delays or reduces the appearance of neuropathy-related pain
hypersensitivity.
4.4. MS aﬀects CCI-induced alterations in growth factor mRNA expression
Neurotrophins such as NGF are additional pro-algesic mediators
released in the spinal cord upon nerve injury (Li et al., 2003). The in-
crease of NGF levels shortly after CCI surgery observed in this study
could result from glial activation-related secretion of IL-1β (Spranger
et al., 1990). This would be in line with the decreased thermal threshold
observed shortly after the CCI surgery in CON animals since NGF is
known to be retrogradely transported to the periphery resulting in a
sensitization of nociceptors (Ji et al., 2002). In addition, TRPM8 a ca-
tion channel able to sense both innocuous and noxious cold, notably
after nerve injury (Xing et al., 2007), has been shown to be upregulated
in a NGF-dependent manner (Babes et al., 2004). In the present study,
NGF mRNA expression was decreased in MS animals shortly after CCI
potentially resulting in a higher cold threshold as compared to controls.
The return to basal mRNA levels at day 21 post-CCI may consequently
have lowered the threshold to cold stimuli. However, the increase of
NGF mRNA levels cannot solely explain the course of cold hyper-
algesia/allodynia since CON+CCI animals presented a decrease of NGF
mRNA levels at 21 days post CCI while remaining highly sensitive.
The implication of GDNF in neuropathic pain is controversial due to
its potent analgesic eﬀect following intrathecal administration (Boucher
et al., 2000) while it can also sensitize nociceptors leading to me-
chanical hyperalgesia (Bogen et al., 2008). The slight decrease in MS
animals and the lack of change in CON animals 4 days after surgery
suggest that GDNF did not participate to a great extent to the estab-
lishment of neuropathic pain. However, given the mechanical threshold
of both groups 21 days after surgery, we hypothesize that GDNF might
have displayed a pro-algesic eﬀect. Indeed, the decrease of GDNF
mRNA expression in the CON group during neuropathy is concomitant
with a reduction of mechanical allodynia/hyperalgesia and the increase
of GDNF mRNA in MS animals would agree with the ongoing decrease
in abnormal mechanical thresholds.
5. Conclusion
Our study surprisingly shows that MS protects from an increase or at
least delays the occurrence of neuropathy-related pain hypersensitivity.
The assessed biochemical markers do not fully reveal the biochemical
cascades involved in the MS-related modiﬁcation of pain thresholds
under neuropathic conditions. Considering that most nociceptive pri-
mary aﬀerents project to the dorsal horn of the spinal cord (Basbaum
et al., 2009), it is conceivable that an analysis of biochemical markers
restricted to the dorsal quadrant would yield stronger eﬀects after CCI
than one that includes dorsal and ventral quadrants as was done here.
Further studies are required to conﬁrm these results and to eventually
elucidate the mechanisms involved in the described stress-related re-
silience to neuropathic pain. In this framework it will be important to
extend the biochemical investigations to the respective protein levels.
Importantly, MS has been shown to have diﬀerential eﬀects on males
and females. Moreover the additionally observed sexual dimorphism in
the framework of neuropathic pain has recently been shown to be
mediated by sex-based diﬀerences in immune responses (Sorge et al.,
2015). It thus remains essential to investigate the impact of MS on
neuropathic pain as potentially underlying sex-dependent mechanisms.
Electrophysiological and pharmacological studies should further add to
the elucidation of these relationships.
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